ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
83.575
-0.07%
US Dollar vs AUD
1.5195
-0.15%
Bitcoin
59,526.20
0.69%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Coeptis Therapeutics Holdings Inc (COEP)

  7. Coeptis Therapeutics Holdings Inc (COEP) News

COEP Coeptis Therapeutics Holdings Inc

0.3696
0.00 (0.00%)
Pre Market
Last Updated: 19:07:31
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Coeptis Therapeutics Holdings Inc COEP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.3696 19:07:31
Open Price Low Price High Price Close Price Previous Close
0.3696
more quote information »

Recent News

Date Time Source Heading
02/5/202422:47PRNUSCoeptis Therapeutics Announces Poster Data Presentation at..
02/4/202423:47PRNUSCoeptis Therapeutics Congratulates Alexander Deiters,..
27/2/202401:00PRNUSCoeptis Therapeutics Adds Autoimmune Indications to..
07/2/202423:30PRNUSCoeptis Therapeutics to Pursue Phase 2 Program Using..
04/1/202423:30PRNUSCoeptis Therapeutics President and CEO Issues Letter to..
01/11/202300:01PRNUSCoeptis Therapeutics Announces Research Demonstrating the..
24/10/202323:30PRNUSCoeptis Therapeutics Announces $2 Million Private Placement
11/10/202322:30PRNUSCoeptis Therapeutics Expands License Agreement with..
10/10/202300:15PRNUSCoeptis Therapeutics to Participate in Panel at the..
04/10/202322:30PRNUSCoeptis Therapeutics Announces Research Involving SNAP-CAR..
27/9/202321:30PRNUSCoeptis Therapeutics to Present at the 2023 Cell & Gene..
14/9/202321:30PRNUSCoeptis Therapeutics Provides Safety and Dosing Update from..
11/9/202321:30PRNUSCoeptis Therapeutics Announces Deverra Therapeutics Has..
31/8/202303:00PRNUSCoeptis Therapeutics Appoints Colleen Delaney, MD, as Chief..
17/8/202321:30PRNUSCoeptis Therapeutics Completes Exclusive License for..
01/8/202322:00PRNUSCoeptis Therapeutics Files FDA 513(g) Submission for CD38 In..
17/6/202306:00PRNUSCoeptis Therapeutics Holdings, Inc. Announces Closing of..
14/6/202323:28PRNUSCoeptis Therapeutics Holdings, Inc. Announces Pricing of..
09/6/202321:00PRNUSCoeptis Therapeutics Receives Approval to Transfer to The..
17/5/202322:30PRNUSCoeptis Therapeutics Appoints Brian Cogley as Chief..
11/5/202305:00PRNUSCoeptis Therapeutics' SNAP-CAR Technology Platform for..

Your Recent History

NASDAQ
COEP
Coeptis Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved